Department of Emergency Medicine, Christiana Care Health System, 4755 Ogletown Stanton Road, Newark, DE 19718, United States of America.
Division of Emergency Medicine, Department of Surgery, University of Vermont Medical Center, 111 Colchester Ave, Burlington, VT 05041, United States of America.
Am J Emerg Med. 2019 Jul;37(7):1285-1288. doi: 10.1016/j.ajem.2018.09.035. Epub 2018 Sep 27.
Use of an age-adjusted D-dimer for the evaluation of acute pulmonary embolus (PE) has been prospectively validated in the literature and has become a practice recommendation from major medical societies. Most research on this subject involves the most common D-dimer assays reporting in Fibrinogen Equivalent Units (FEU) with a non-age-adjusted manufacturer-recommended cutoff of 500 ng/ml FEU. Limited research to date has evaluated age-adjustment in assays that report in D-Dimer Units (D-DU), which use a manufacturer-recommended cutoff of 230 ng/ml D-DU. Despite scant evidence, an age-adjusted formula using D-DU has been recently endorsed by the American College of Emergency Physicians (ACEP). This formula seems arbitrary in its derivation and unnecessarily deviates from existing thresholds, thus prompting the creation of our novel-age adjustment formula. The goal of this study was to retrospectively evaluate the test characteristics of our novel age-adjusted D-dimer formula using the D-DU assay in comparison to existing traditional and age-adjusted D-dimer thresholds for the evaluation of acute PE in the ED.
This was a retrospective chart review at an academic quaternary health system with three EDs and 195,000 combined annual ED visits. Only patients with D-dimer testing and CT PE protocol (CTPE) imaging were included. Admission and discharge diagnosis codes were used to identify acute PE. Outcome measures were sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) of an unadjusted traditional threshold (230) compared with both novel and ACEP-endorsed age adjusted thresholds, (Age × 5) - 20 and Age × 5 if >50, respectively. Estimates with their exact 95% threshold were performed.
4846 adult patients were evaluated from January 2012 to July 2017. Group characteristics include a mean age of 52 and a frequency of acute PE diagnosis by CTPE of 8.25%. Traditional D-dimer cutoff demonstrated a sensitivity of 99.8% (95% CI 98.6-100), specificity of 16.7% (95% CI 15.6-17.8) and NPV of 99.9% (95% CI 99.3-100). Our novel age-adjusted D-dimer thresholds had a sensitivity of 97.0% (95% CI 94.8-98.4), specificity of 27.9% (95% CI 26.6-29.2) and NPV of 99.0% (95% CI 98.3-99.5) with the ACEP-endorsed formula demonstrating similar test characteristics.
Use of an age-adjusted D-dimer on appropriately selected patients being evaluated for acute PE in the ED with a D-DU assay increases specificity while maintaining a high sensitivity and NPV. Both our novel formula and the ACEP-endorsed age-adjusted formula performed well, with our novel formula showing a trend towards improved testing characteristics.
年龄调整的 D-二聚体用于评估急性肺栓塞(PE)已经在文献中得到了前瞻性验证,并成为主要医学协会的实践推荐。大多数关于这一主题的研究都涉及最常见的 D-二聚体检测,以纤维蛋白原当量单位(FEU)报告,未调整年龄的制造商建议截断值为 500ng/ml FEU。迄今为止,有限的研究评估了在以制造商建议的 230ng/ml D-二聚体单位(D-DU)报告的检测中进行年龄调整,尽管证据不足,但最近美国急诊医师学院(ACEP)认可了一种使用 D-DU 的年龄调整公式。该公式在推导上似乎很随意,并且不必要地偏离了现有的阈值,因此促使我们创建了新的年龄调整公式。本研究的目的是使用 D-DU 检测,回顾性评估我们新的年龄调整 D-二聚体公式的检测特性,并与 ED 中用于评估急性 PE 的现有传统和年龄调整 D-二聚体阈值进行比较。
这是在一家拥有三个急诊部和 195,000 次年度急诊就诊量的学术四级医疗系统中进行的回顾性图表审查。仅纳入接受 D-二聚体检测和 CTPE 成像的患者。入院和出院诊断代码用于识别急性 PE。评估指标为未经调整的传统阈值(230)与新的和 ACEP 认可的年龄调整阈值(Age×5)-20 和年龄>50 时的年龄×5 的敏感性、特异性、阴性预测值(NPV)和阳性预测值(PPV)。使用其精确的 95%阈值进行估计。
2012 年 1 月至 2017 年 7 月期间共评估了 4846 例成年患者。组特征包括平均年龄为 52 岁,CTPE 诊断急性 PE 的频率为 8.25%。传统 D-二聚体截断值显示敏感性为 99.8%(95%CI 98.6-100),特异性为 16.7%(95%CI 15.6-17.8),NPV 为 99.9%(95%CI 99.3-100)。我们新的年龄调整 D-二聚体阈值的敏感性为 97.0%(95%CI 94.8-98.4),特异性为 27.9%(95%CI 26.6-29.2),NPV 为 99.0%(95%CI 98.3-99.5),ACEP 认可的公式具有相似的检测特征。
在 ED 中对接受 D-DU 检测的急性 PE 患者进行年龄调整的 D-二聚体检测可提高特异性,同时保持高敏感性和 NPV。我们新的公式和 ACEP 认可的年龄调整公式都表现良好,我们新的公式显示出改善检测特征的趋势。